# Integrated effects of altered action potentials and calcium release on skeletal muscle force generation in transgenic Huntington’s disease mice

**Authors:** Daniel R. Miranda, Steven R. A. Burke, Pooneh Hajmirza Mohammadi Kamalabadi, Julia L. Rutherford, John Kamau, Hugo Bibollet, Robert J. Talmadge, Gerald M. Wilson, Abhyudai Singh, Volker Bahn, Hongmei Ren, Erick Hernández-Ochoa, Andrew A. Voss

PMC · DOI: 10.1007/s00424-026-03151-6 · Pflugers Archiv · 2026-02-19

## TL;DR

This study explores how changes in muscle cell electrical activity and calcium release affect muscle strength in Huntington’s disease mice.

## Contribution

The study reveals an integrated multi-molecular mechanism explaining muscle function in HD despite conflicting cellular changes.

## Key findings

- Reduced calcium release does not cause muscle weakness due to prolonged calcium release and altered calcium-binding proteins.
- The integrated mechanism explains normal twitch force and resistance to myotonia in HD muscle.
- The balance of mechanisms breaks down under mild repetitive stimulation, showing a precarious system.

## Abstract

Huntington’s disease (HD) is a movement disorder commonly recognized as being neurodegenerative. An increasing number of studies also show primary HD dysfunction in multiple tissues, consistent with the widespread expression of the mutated huntingtin gene. Studies of HD skeletal muscle have revealed membrane hyperexcitability and prolonged action potentials due to Cl– and K+ channel dysfunction as well as decreased Ca2+ release from the sarcoplasmic reticulum (SR) due to ryanodine receptor dysfunction. However, neither mechanism alone explains HD skeletal muscle function. To address this, we simultaneously recorded action potentials and SR Ca2+ release in model HD muscle and quantitatively linked the concerted mechanism to force generation. We discovered that the reduced SR Ca2+ release does not cause weakness in model HD muscle as expected because of the prolonged SR Ca2+ release (due to wider action potentials) and altered expression of Ca2+-binding proteins. The resulting integrated mechanism helps explains the surprisingly normal specific twitch force in model HD muscle and reveals a precarious balance that we show begins to disintegrate under very mild repetitive stimulation. The interplay of pathways also explains the resistance to myotonia in model HD muscle despite the substantial reduction in Cl− current. By examining a concerted multi-molecular mechanism, we are able to understand tissue-level function in model HD muscle. This detailed study of twitch responses lays the foundation to examine the more complex integration of pathways during repetitive activity in HD muscle as well as in other normal and disease states that would benefit from the multi-molecular approach.

## Linked entities

- **Genes:** LOC101450258 (uncharacterized LOC101450258) [NCBI Gene 101450258]
- **Chemicals:** Cl− (PubChem CID 312), K+ (PubChem CID 813), Ca2+ (PubChem CID 271)
- **Diseases:** Huntington’s disease (MONDO:0007739)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Kcnc4 (potassium voltage gated channel, Shaw-related subfamily, member 4) [NCBI Gene 99738] {aka KSHIIIC, Kcr2-4, Kv3.4}, Casq2 (calsequestrin 2) [NCBI Gene 12373] {aka Csq2, ESTM52, cCSQ}, Pvalb (parvalbumin) [NCBI Gene 19293] {aka PV, Parv, Pva}, Clcn1 (chloride channel, voltage-sensitive 1) [NCBI Gene 12723] {aka Clc-1, Clc1, SMCC1, adr, mto, myotonia}, Ryr3 (ryanodine receptor 3) [NCBI Gene 20192] {aka C230090H21, RYR-3}, Myh4 (myosin, heavy polypeptide 4, skeletal muscle) [NCBI Gene 17884] {aka MHC2B, MM, MYH-2B, Minimsc, Minmus, MyHC-IIb}, Calm4 (calmodulin 4) [NCBI Gene 80796] {aka 2310037J09Rik, DD112, Scarf}, Myhc (myosin heavy chain, cardiac muscle complex) [NCBI Gene 111671], Atp2b2 (ATPase, Ca++ transporting, plasma membrane 2) [NCBI Gene 11941] {aka D6Abb2e, Gena300, PMCA2, Tmy, dfw, jog}, Atp2a2 (ATPase, Ca++ transporting, cardiac muscle, slow twitch 2) [NCBI Gene 11938] {aka 9530097L16Rik, D5Wsu150e, SERCA2, SERCA2B, Serca2a, mKIAA4195}, Cacna1s (calcium channel, voltage-dependent, L type, alpha 1S subunit) [NCBI Gene 12292] {aka Cav1.1, Cchl1a3, DHPR, DHPR alpha1s, fmd, mdg}, Trdn (triadin) [NCBI Gene 76757] {aka 2310045H21Rik, EG432451, TDN}, Slc8a1 (solute carrier family 8 (sodium/calcium exchanger), member 1) [NCBI Gene 20541] {aka D930008O12Rik, Ncx1}, Casq1 (calsequestrin 1) [NCBI Gene 12372] {aka CSQ, CSQ-1, CSQ1, sCSQ}, Htt (huntingtin) [NCBI Gene 15194] {aka C430023I11Rik, Hd, Hdh, IT15}, Ryr2 (ryanodine receptor 2, cardiac) [NCBI Gene 20191] {aka 9330127I20Rik, RYR-2}, Ryr1 (ryanodine receptor 1, skeletal muscle) [NCBI Gene 20190] {aka RYR-1, Ryr, skrr}, Myh1 (myosin, heavy polypeptide 1, skeletal muscle, adult) [NCBI Gene 17879] {aka A530084A17Rik, IId, IId/x, MHC-2X/D, MHC2X/D, MYHC-IIX}, Tnnc1 (troponin C, cardiac/slow skeletal) [NCBI Gene 21924] {aka TnC, cTnC, cTnI, tncc}, Fkbp1a (FK506 binding protein 1a) [NCBI Gene 14225] {aka FKBP12, Fkbp, Fkbp1}, Mcu (mitochondrial calcium uniporter) [NCBI Gene 215999] {aka 2010012O16Rik, C10orf42, Ccdc109a, D130073L02Rik, Gm64}, Atp2a3 (ATPase, Ca++ transporting, ubiquitous) [NCBI Gene 53313] {aka SERCA3b, Serca3}, HTT (huntingtin) [NCBI Gene 3064] {aka HD, IT15, LOMARS}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Atp2a1 (ATPase, Ca++ transporting, cardiac muscle, fast twitch 1) [NCBI Gene 11937] {aka SERCA1}, Stim1 (stromal interaction molecule 1) [NCBI Gene 20866] {aka SIM}, S100a1 (S100 calcium binding protein A1) [NCBI Gene 20193] {aka S100, S100a}, Tnnc2 (troponin C2, fast) [NCBI Gene 21925] {aka Tncs}, Kcna5 (potassium voltage-gated channel, shaker-related subfamily, member 5) [NCBI Gene 16493] {aka Kv1.5}
- **Diseases:** weakness (MESH:D018908), HD (MESH:D006816), weight loss (MESH:D015431), atrophy (MESH:D001284), muscle atrophy (MESH:D009133), neurodegeneration (MESH:D019636), metabolic and mitochondrial defects (MESH:C565376), myotonia (MESH:D009222), metabolic dysfunction (MESH:D008659), EDL muscle (MESH:C565945), muscle fiber hyperexcitability (MESH:C563545), neuromuscular and skeletal muscle defects (MESH:D009468), prolonged AP repolarization (MESH:D008133), EDL (MESH:D009127), monogenic disorder (MESH:D009358), impairment of movement (MESH:D009069), cognitive and movement dysfunction (MESH:D003072), muscle contracture (MESH:D003286), muscle degeneration (MESH:D009410), skeletal muscle dysfunction (MESH:D009135), R6/2 (MESH:D020803)
- **Chemicals:** MOPS (MESH:C008550), Nonidet P-40 (MESH:C010615), Ca(OH)2 (MESH:D002126), MgSO4 (MESH:D008278), EDTA (MESH:D004492), Cl- (MESH:D002713), agar (MESH:D000362), Oil (MESH:D009821), MgCl2 (MESH:D015636), ATP di-Na (-), NaHCO3 (MESH:D017693), BTS (MESH:D019289), 4-aminopyridine (MESH:D015761), NaCl (MESH:D012965), K+ (MESH:D011188), Na+ (MESH:D012964), fluo-4 (MESH:C409648), CaCl2 (MESH:D002122), Tween 20 (MESH:D011136), KCl (MESH:D011189), HCl (MESH:D006851), PVDF (MESH:C024865), tetrodotoxin (MESH:D013779), SDS (MESH:D012967), glucose (MESH:D005947), Ca (MESH:D002118), chloride (MESH:D002712), water (MESH:D014867), ATP (MESH:D000255), Cs+ (MESH:D002586), 9-anthracene-carboxylic acid (MESH:C010030), D-mannitol (MESH:D008353), CO2 (MESH:D002245), EGTA (MESH:D004533), isoflurane (MESH:D007530), TEA (MESH:D019789), Flux (MESH:C040639), KOH (MESH:C029943)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** /2 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_A628), R6/2 — Mus musculus (Mouse), Hybridoma (CVCL_9233)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12916976/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12916976/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12916976/full.md

---
Source: https://tomesphere.com/paper/PMC12916976